Cite
Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study
MLA
Anne Bozon, et al. “Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under Biologics: A Prospective, Multicenter, Observational, One-Year Follow-up Comparative Study.” Clinics and Research in Hepatology and Gastroenterology, vol. 47, May 2023, p. 102107. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........12528c622ff547fe1126b5bb0a8c68ef&authtype=sso&custid=ns315887.
APA
Anne Bozon, Stéphane Nancey, Mélanie Serrero, Ludovic Caillo, Cyrielle Gilletta, Alban Benezech, Roman Combes, Guillaume Danan, Sandrine Akouete, Laurence Pages, Jean-François Bourgaux, Guillaume Le Cosquer, Lucile Boivineau, Magdalena Meszaros, & Romain Altwegg. (2023). Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study. Clinics and Research in Hepatology and Gastroenterology, 47, 102107.
Chicago
Anne Bozon, Stéphane Nancey, Mélanie Serrero, Ludovic Caillo, Cyrielle Gilletta, Alban Benezech, Roman Combes, et al. 2023. “Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under Biologics: A Prospective, Multicenter, Observational, One-Year Follow-up Comparative Study.” Clinics and Research in Hepatology and Gastroenterology 47 (May): 102107. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........12528c622ff547fe1126b5bb0a8c68ef&authtype=sso&custid=ns315887.